Insulin Variance Throughout the Day
NCT01546545 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11
Last updated 2024-03-07
Summary
This study is designed to determine whether the sensitivity of a participant's insulin varies from the morning to the evening.
Conditions
- Insulin Sensitivity
Sponsors & Collaborators
-
Jenny Craig, Inc.
collaborator INDUSTRY -
Pennington Biomedical Research Center
lead OTHER
Principal Investigators
-
Jeffrey Gimble, MD, PhD · Pennington Biomedical Research Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
Countries
- United States
Study Locations
More Related Trials
-
Study TO Prevent Diabetes With Short-term Insulin Glargine Only
NCT01276912 ·Status: UNKNOWN ·Phase: NA
-
Glucose Variability in Subclinical Hypertrophy
NCT02748434 ·Status: TERMINATED ·Phase: NA
-
GLP-1 Infusion and Long-Time Fasting
NCT00285896 ·Status: COMPLETED ·Phase: NA
-
Incretin Effect in Lean and Obese Subjects
NCT00803296 ·Status: COMPLETED
-
Insulin Resistance and Insulin Secretion
NCT00073294 ·Status: WITHDRAWN ·Phase: NA
-
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
NCT06976619 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
NCT02089256 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin
NCT04034524 ·Status: UNKNOWN
-
Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction
NCT05244694 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of 10-day Overnight Hypoxia Treatment on Whole Body Insulin Sensitivity (SLEEP HIGH Study)
NCT01872533 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity
NCT03318094 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
GLP1R Polymorphisms and Response to GLP1
NCT00588380 ·Status: COMPLETED ·Phase: NA
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT01663220 ·Status: COMPLETED
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
NCT04466566 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
NCT06967558 ·Status: RECRUITING ·Phase: PHASE2
-
Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects
NCT03991299 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans
NCT06972407 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
NCT02611232 ·Status: UNKNOWN ·Phase: PHASE2
-
GLP-1/Basal Insulin Combination Therapy
NCT02895672 ·Status: COMPLETED
-
The Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity in Type 2 Diabetes
NCT01202526 ·Status: COMPLETED
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Insulin and Insulin Pulses During Fasting
NCT06424015 ·Status: RECRUITING ·Phase: NA
-
Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1
NCT05960565 ·Status: TERMINATED ·Phase: PHASE2